King’s College London plays major role in £50 million government funded programme into mental health research

King’s researchers will help transform mental health data, clinical trials and industry partnerships as part of the UK Government’s Mental Health Goals programme.

By NIHR Maudsley BRC at 29 Jan 2026
Read more >

Researchers identify genetic blueprint of mania in bipolar disorder

Researchers at King’s College London and the University of Florence have, for the first time, identified the specific genetic blueprint of mania, the defining feature of bipolar disorder.

 

By NIHR Maudsley BRC at 28 Jan 2026
Read more >

Brain device for ADHD shows no benefit in major UK trial

Diagnoses of attention deficit hyperactivity disorder (ADHD) are rising rapidly in the UK. More children and teenagers than ever are being referred for assessment and support, and families are often facing long waits and limited options once a diagnosis is made. Schools, health services and parents are all under growing pressure to find treatments that genuinely help children manage their difficulties with attention, impulsivity and activity levels.

 

By NIHR Maudsley BRC at 23 Jan 2026
Read more >

Young people may temporarily withdraw from social media use on the day they self-harm

New research from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London, in partnership with YoungMinds, has examined the image-posting habits on social media of young people who self-harm. The study found that young people temporarily withdraw from posting images on the day they self-harm.

By NIHR Maudsley BRC at 21 Jan 2026
Read more >

Brain stimulation device cleared for ADHD in the US is overall safe but ineffective

A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

 

By NIHR Maudsley BRC at 16 Jan 2026
Read more >